IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-2/CD40-activated macrophages rescue age and tumor-induced T cell dysfunction in elderly mice
Authors
Keywords
Innate immunity, Elderly, Immune restoration, Cancer immunotherapy, Macrophage, T cell
Journal
AGE
Volume 36, Issue 3, Pages -
Publisher
Springer Nature
Online
2014-04-18
DOI
10.1007/s11357-014-9655-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice
- (2013) Connie Jackaman et al. AGING CELL
- Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy
- (2013) Myriam N. Bouchlaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer
- (2013) Chris P. Verschoor et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
- (2012) Connie Jackaman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Rejuvenation of Regeneration in the Aging Central Nervous System
- (2012) Julia M. Ruckh et al. Cell Stem Cell
- IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase
- (2012) Connie Jackaman et al. INTERNATIONAL IMMUNOLOGY
- Aging Enhances the Production of Reactive Oxygen Species and Bactericidal Activity in Peritoneal Macrophages by Upregulating Classical Activation Pathways
- (2011) Heather S. Smallwood et al. BIOCHEMISTRY
- Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma
- (2011) Bryan M. Burt et al. CANCER
- Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses
- (2011) Connie Jackaman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Advanced Age Impairs Macrophage Polarization
- (2011) Shegufta Mahbub et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8+Cells
- (2010) Zvi G. Fridlender et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Potential role of immunosenescence in cancer development
- (2010) Tamas Fulop et al. Annals of the New York Academy of Sciences
- Cytokine-armed vaccinia virus infects the mesothelioma tumor microenvironment to overcome immune tolerance and mediate tumor resolution
- (2010) C Jackaman et al. CANCER GENE THERAPY
- In Aged Mice, Outgrowth of Intraocular Melanoma Depends on Proangiogenic M2-Type Macrophages
- (2010) L. V. Ly et al. JOURNAL OF IMMUNOLOGY
- Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels
- (2009) Rong Yuan et al. AGING CELL
- Delayed but excellent myogenic stem cell response of regenerating geriatric skeletal muscles in mice
- (2009) Thea Shavlakadze et al. BIOGERONTOLOGY
- Effects of aging on T cell function
- (2009) Laura Haynes et al. CURRENT OPINION IN IMMUNOLOGY
- Antigen-specific Treg impair CD8+T-cell priming by blocking early T-cell expansion
- (2009) Pascal Chappert et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells
- (2009) C. Jackaman et al. EUROPEAN RESPIRATORY JOURNAL
- Deliberately provoking local inflammation drives tumors to become their own protective vaccine site
- (2008) Connie Jackaman et al. INTERNATIONAL IMMUNOLOGY
- Designing ageing conditions in tumour microenvironment—A new possible modality for cancer treatment
- (2008) Judith Leibovici et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Effect of Senescence on Macrophage Polarization and Angiogenesis
- (2008) Dru S. Dace et al. REJUVENATION RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started